Variant report
Variant | nsv516207 |
---|---|
Chromosome Location | chr4:125841892-125846118 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs7356273 | chr4:125841892-125841893 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
2 | rs185892480 | chr4:125841895-125841896 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs571852855 | chr4:125841937-125841938 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs557427930 | chr4:125841946-125841947 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs139560854 | chr4:125841998-125841999 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs553417929 | chr4:125842020-125842021 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs11475754 | chr4:125842023-125842024 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs568488677 | chr4:125842044-125842045 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs116610559 | chr4:125842047-125842048 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs7356274 | chr4:125842087-125842088 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
11 | rs562038125 | chr4:125842103-125842104 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs4834009 | chr4:125842156-125842157 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
13 | rs188499092 | chr4:125842166-125842167 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs145792363 | chr4:125842171-125842172 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs33971797 | chr4:125842172-125842173 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs111877147 | chr4:125842173-125842174 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs34858177 | chr4:125842174-125842175 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs142759435 | chr4:125842188-125842189 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs115339450 | chr4:125842189-125842190 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs551911316 | chr4:125842235-125842236 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs570126479 | chr4:125842241-125842242 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs59952820 | chr4:125842265-125842266 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs199717411 | chr4:125842269-125842270 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs386679257 | chr4:125842270-125842271 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs368945818 | chr4:125842273-125842274 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs71583380 | chr4:125842274-125842275 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs7356505 | chr4:125842277-125842278 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs144870874 | chr4:125842281-125842282 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs13435791 | chr4:125842309-125842310 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
30 | rs1909101 | chr4:125842342-125842343 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
31 | rs571714197 | chr4:125842362-125842363 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs180898674 | chr4:125842368-125842369 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs557447171 | chr4:125842382-125842383 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs540959765 | chr4:125842431-125842432 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs1909100 | chr4:125842481-125842482 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
36 | rs200947817 | chr4:125842489-125842490 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs1483595 | chr4:125842490-125842491 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
38 | rs10470922 | chr4:125842539-125842540 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
39 | rs28627553 | chr4:125842550-125842551 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
40 | rs10518455 | chr4:125842552-125842553 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
41 | rs1483594 | chr4:125842641-125842642 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
42 | rs533377283 | chr4:125842663-125842664 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs551769717 | chr4:125842690-125842691 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs4464585 | chr4:125842704-125842705 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs10470923 | chr4:125842724-125842725 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
46 | rs145241822 | chr4:125842731-125842732 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs192036000 | chr4:125842738-125842739 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs147370795 | chr4:125842751-125842752 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs200632761 | chr4:125842754-125842755 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs35045964 | chr4:125842755-125842756 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Acute lymphoblastic leukemia | 22237106 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Chordoma | 21602918 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 21858162 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Gastric cancer | 21586687 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Breast cancer | 17603634 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Breast cancer | 16272173 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
4q-syndrome | 17576883 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Muscular dystrophy | 21149563 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cervical cancer | 21062161 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Breast cancer | 16608533 | CNVD |
Lung cancer | 19208797 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 21785460 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Lung cancer | 18438408 | CNVD |
Cancer | 22429812 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Cancer | 21183584 | CNVD |
primary effusion lymphomas | 17116491 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 17133270 | CNVD |
Colorectal cancer | 20459617 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Congenital anomalies of the kidney and urinary tract | 20505237 | CNVD |
Breast cancer | 17393978 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Neuroblastoma | 21899760 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Developmental delay | 21147756 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Ovarian cancer | 21781307 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr4:125835400-125844400 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
2 | chr4:125835400-125844400 | Weak transcription | Foreskin Keratinocyte Primary Cells skin02 | Skin |
3 | chr4:125843800-125844000 | Enhancers | Lung | lung |
4 | chr4:125844400-125844800 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
5 | chr4:125844400-125845000 | Enhancers | Foreskin Keratinocyte Primary Cells skin02 | Skin |
6 | chr4:125844400-125845000 | Enhancers | NHEK | skin |
7 | chr4:125844400-125845600 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
8 | chr4:125844600-125845000 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
9 | chr4:125844600-125845000 | Enhancers | Cortex derived primary cultured neurospheres | brain |
10 | chr4:125844600-125845000 | Enhancers | Ganglion Eminence derived primary cultured neurospheres | brain |
11 | chr4:125844600-125845000 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
12 | chr4:125844600-125845000 | Enhancers | Fetal Heart | heart |
13 | chr4:125844600-125845000 | Enhancers | HMEC | breast |
14 | chr4:125844800-125860600 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
15 | chr4:125845000-125846800 | Weak transcription | Fetal Heart | heart |
16 | chr4:125845600-125857600 | Weak transcription | Foreskin Melanocyte Primary Cells skin03 | Skin |